Ultrasonographic Evaluation of Vincristine-Induced Gastric Hypomotility and the Prokinetic Effect of Mosapride in Dogs

Journal of Veterinary Internal Medicine

Volumn 25, Issue 6, 2011, Pages 1461-1464

  Tsukamoto, A ^a   Ohno, K ^a   Tsukagoshi, T ^a   Maeda, S ^a   Nakashima, K ^a   Fukushima, K ^a   Fujino, Y ^a   Takeuchi, A ^b   Tsujimoto, H ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Chemotherapy; Gastrointestinal adverse event; Gastrointestinal motility disorder; Prokinetics

Indexed keywords

ANTINEOPLASTIC AGENT; BENZAMIDE DERIVATIVE; GASTROINTESTINAL AGENT; MORPHOLINE DERIVATIVE; MOSAPRIDE; VINCRISTINE;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DOG; DOG DISEASE; DRUG ADMINISTRATION; FEMALE; MALE;

ANIMALS; ANTINEOPLASTIC AGENTS; BENZAMIDES; DOG DISEASES; DOGS; DRUG ADMINISTRATION SCHEDULE; FEMALE; GASTROINTESTINAL AGENTS; MALE; MORPHOLINES; VINCRISTINE;

ANIMALIA; CANIS FAMILIARIS;

EID: 81355138246     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2011.00795.x     Document Type: Article

References (10)

1. Withrow SJ, David VM. Withrow & MacEwen's Small Animal Clinical Oncology. In: Withrow SJ, David VM, eds. Cancer Chemotherapy, 4 ed. St. Louis, MO: Saunders, an imprint of Elsevier Inc; 2007:784.
2. Tomiyasu H, Takahashi M, Fujino Y, et al. Gastrointestinal and hematologic adverse events after administration of vincristine, cyclophosphamide, and doxorubicin in dogs with lymphoma that underwent a combination multidrug chemotherapy protocol. J Vet Med Sci 2010;72:1391-1397.
3. Tomomasa T, Miyazawa R, Kato M, et al. Prolonged gastrointestinal dysmotility in a patient with hemophagocytic lymphohistiocytosis treated with vincristine. Dig Dis Sci 1999; 44:1755-1757.
4. Thamm DH, Vail DM. Aftershocks of cancer chemotherapy: Managing adverse effects. J Am Anim Hosp Assoc 2007; 43:1-7.
5. Curran MP, Robinson DM. Mosapride in gastrointestinal disorders. Drugs 2008; 68:981-991.
6. Yoshida N, Ito T, Karasawa T, et al. AS-4370, a new gastrokinetic agent, enhances upper gastrointestinal motor activity in conscious dogs. J Pharmacol Exp Ther 1991;257:781-787.
7. Tsukamoto A, Ohno K, Tsukagoshi T, et al Real-time ultrasonographic evaluation of canine gastric motility in the postprandial state. J Vet Med Sci 2011;73:1133-1138.
8. Veterinary Co-operative Oncology Group. Common Terminology Criteria for Adverse Events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.0. Vet Comp Oncol 2004;2:195-213.
9. Garewal HS, Dalton WS. Metoclopramide in vincristine-induced ileus. Cancer Treat Rep 1985;69:1309-1311.
10. Yatera S, Koujitani T, Yasuba M, et al. Toxicity study of mosapride citrate (3). Thirteen-week repeated dose oral toxicity study in Beagle dogs. Jpn Pharmacol Ther 1993;21:57-73.